RFK Jr. orders a review of mifepristone — but let’s not forget who helped shove it through in the first place.
While RFK Jr. has called for a review of mifepristone, we can’t ignore how the FDA rushed it through under political pressure from the very beginning.
It took until 2025, but someone in Washington finally got around to questioning the abortion pill. And no, it’s not the “Republican” establishment. It’s HHS Secretary Robert F. Kennedy Jr., who just ordered Dr. Marty Makary to lead a comprehensive review of mifepristone.
That’s the abortion pill responsible for ending millions of pregnancies — and sending thousands of women to the ER.
Health and Human Services Secretary Robert F. Kennedy Jr. revealed Wednesday that he has ordered the Food and Drug Administration (FDA) to conduct a “complete review” of a chemical abortion pill amid reports that the drug isn’t as safe as advertised.
“It’s alarming,” RFK Jr. said of a recent study conducted by the Ethics & Public Policy Center that found nearly 11% of women who used the popular abortion pill mifepristone experienced a “serious adverse event.”
“I have asked Marty Makary, who is the director at FDA, to do a complete review and report back,” the HHS secretary revealed during a Senate Health, Labor, Education and Pensions Committee hearing. – New York Post
The Abortion Pill Was Fast-Tracked Like a Cancer Drug—But Pregnancy Isn’t a Disease
This drug didn’t just pop out of a lab with a shiny FDA seal and a clean safety record. Mifepristone’s fast-track approval in 2000 was a political gift to the abortion industry. The Clinton FDA cut corners, bent rules, and used a shady process meant for treating life-threatening illnesses. Pregnancy, for the record, is not a disease.
Fast forward to now, and RFK Jr. is doing what no one else in D.C. seems to have the guts to do: questioning Big Pharma’s grip on abortion and exposing the FDA’s role in pushing dangerous drugs under the guise of “reproductive freedom.”
Dr. Makary isn’t exactly a firebrand, but he’s no fool. And while he hasn’t publicly declared war on the abortion pill (yet), the numbers don’t lie. According to the FDA’s own data, anywhere from 2.9% to 4.6% of women who take mifepristone wind up in the emergency room. That’s roughly 1 in 25. Let that sink in.
Makary has said he’ll review the drug based on the evidence—and if new data supports action, he’ll take it. But here’s the thing: the evidence has been hiding in plain sight for years. The FDA has known these numbers. They approved the pill anyway, and they’ve done nothing to warn the public since. If that’s not regulatory malpractice, I don’t know what is.
The abortion pill is used to kill 1,777 babies every day in the United States—that’s 74 every hour, or one every 49 seconds.
A new study shows it also places women’s lives in grave danger. Ban the abortion pill @US_FDA! pic.twitter.com/USOMU19iG3
— Lila Rose (@LilaGraceRose) May 9, 2025
Secret Investors Built the Pill. The FDA Just Signed the Permission Slip
And let’s talk about the FDA — the same agency that calls itself the gold standard while playing lapdog to private equity, activist groups, and abortion lobbyists. According to Mother Jones (yes, even they admitted it), the makers of mifepristone used a network of secretive investors and shell companies to develop and market the drug — all while dodging transparency and accountability. The FDA shrugged and stamped it anyway.
This wasn’t about safety. It was about speed and politics. The abortion lobby pushed to cement chemical abortion as the go-to method—before the public caught on.
Mifepristone’s Origins Sound More Like a Spy Thriller Than Medical Science
In their warehouse, they got to work building an underground drug laboratory, complete with a huge, customized ventilation hood, fire prevention devices, and specially designed sinks. The whole project “had the trappings of a CIA operation,” Lader would later write. They figured out a system for replenishing their near-constant need for dry ice from a supplier 15 miles away, and crafted a strategy to avoid detection by anti-abortion groups, the garbage collector, and their landlord. If anyone asked what they were up to, the group—which included a doctor who lived 1,000 miles away and asked to go by Dr. X; a Columbia University chemist working for free; and two assistants—agreed on a cover story: They were working on a new treatment for cancer.
Meanwhile, Roussel-Uclaf and its parent company were in a drawn-out negotiation with a Manhattan-based reproductive health nonprofit, called the Population Council, over the official patent for RU-486. The same month that the French company finally agreed to give the Council the patent, Lader’s secret lab announced that it had successfully developed its own copy of the drug, whose scientific name is mifepristone. The two groups knew of each other’s work, and Lader had even reached out to the Population Council about collaborating, but the Council had demurred.
Backdoor Approval and Small-Batch Abortions: The FDA Played Along
And here’s more from the Mother Jones article, from 2023.
Lader’s group knew American women could not wait the many years it would take for the Council to arrange an official manufacturing operation with full approval from the Food and Drug Administration. So, it got its own permission from the FDA to conduct limited testing, which would allow it to start distributing small batches of the drug to a network of 10 clinics.
[…]
For the few who were able to try it, it was an emotional and physical relief: It meant they could have an abortion privately and without a vacuum aspiration machine, whose suction “feels like you’re getting the life sucked out of you,” as one early mifepristone recipient described it to the Boston Globe. – Mother Jones
…vacuum aspiration machine, ‘whose suction “feels like you’re getting the life sucked out of you,”‘ – that’s because it is ma’am.
Mifepristone Deserves Scrutiny—Not Baldwin’s Yes-or-No Games
In this clip, Senator Tammy Baldwin doesn’t ask questions—she sets traps. With her black-and-white script and smug delivery, she tries to corner RFK Jr. into declaring his stance on mifepristone with a simple yes or no, hoping to spin it later. But chemical abortion isn’t simple. And neither is the FDA’s long, shady history of fast-tracking this drug under political pressure. While Baldwin performs outrage for the cameras, my blog post lays out what she conveniently ignores: the risks to women, the shell games behind mifepristone’s approval, and why this pill was never about “choice”—it was always about control.
Abortion Pills Aren’t Healthcare
Well, here’s the truth: abortion pills are not healthcare. They are not empowering. They’re marketed lies wrapped in medical jargon. And the damage they cause — to women and to unborn children — is measurable, visible, and unforgivable.
So no, I’m not applauding RFK Jr. for suddenly being pro-life because he’s really not. But I’ll give credit where it’s due: someone finally cracked open the FDA’s vault and asked what’s really inside. And what we’re seeing? It’s not medicine — it’s a cover-up.
It’s time to recall mifepristone. The science is clear. The risk is real. And the silence, up until now, has been deliberate.
From OxyContin to abortion pills, the FDA’s track record speaks for itself—rubber-stamp it now, deal with the fallout later. This is the same agency that let a generation get hooked on opioids, fast-tracked mifepristone under political pressure, and cozied up to private equity firms posing as healthcare innovators. When pharma lobbyists write the playbook and unelected bureaucrats follow it, the result isn’t safety—it’s a system that profits off pain, silence, and death.
Feature Image: Gage Skidmore from Surprise, AZ, United States of America, CC BY-SA 2.0, via Wikimedia Commons/edited in Canva Pro
_(cropped).jpg){kind=link}